Clinical practice guideline for screening and management of high blood pressure in children and adolescents

SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN

Research output: Contribution to journalReview article

359 Citations (Scopus)

Abstract

These pediatric hypertension guidelines are an update to the 2004 "Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents." Significant changes in these guidelines include (1) the replacement of the term "prehypertension" with the term "elevated blood pressure, " (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.

Original languageEnglish (US)
Article numbere20171904
JournalPediatrics
Volume140
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Practice Management
Practice Guidelines
Blood Pressure
Hypertension
Guidelines
Pediatrics
Prehypertension
Ambulatory Blood Pressure Monitoring
Preventive Medicine
Left Ventricular Hypertrophy
Echocardiography
Weights and Measures

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN (2017). Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics, 140(3), [e20171904]. https://doi.org/10.1542/peds.2017-1904

Clinical practice guideline for screening and management of high blood pressure in children and adolescents. / SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN.

In: Pediatrics, Vol. 140, No. 3, e20171904, 01.09.2017.

Research output: Contribution to journalReview article

SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN 2017, 'Clinical practice guideline for screening and management of high blood pressure in children and adolescents', Pediatrics, vol. 140, no. 3, e20171904. https://doi.org/10.1542/peds.2017-1904
SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017 Sep 1;140(3). e20171904. https://doi.org/10.1542/peds.2017-1904
SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. / Clinical practice guideline for screening and management of high blood pressure in children and adolescents. In: Pediatrics. 2017 ; Vol. 140, No. 3.
@article{8221df3c001641c8ac5e20cf7da09a6c,
title = "Clinical practice guideline for screening and management of high blood pressure in children and adolescents",
abstract = "These pediatric hypertension guidelines are an update to the 2004 {"}Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.{"} Significant changes in these guidelines include (1) the replacement of the term {"}prehypertension{"} with the term {"}elevated blood pressure, {"} (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.",
author = "{SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN} and Flynn, {Joseph T.} and Kaelber, {David C.} and Baker-Smith, {Carissa M.} and Douglas Blowey and Aaron Carroll and Daniels, {Stephen R.} and {De Ferranti}, {Sarah D.} and Dionne, {Janis M.} and Bonita Falkner and Flinn, {Susan K.} and Gidding, {Samuel S.} and Celeste Goodwin and Leu, {Michael G.} and Powers, {Makia E.} and Corinna Rea and Joshua Samuels and Madeline Simase and Thaker, {Vidhu V.} and Urbina, {Elaine M.} and Madeline Simasek and Kymika Okechukwu",
year = "2017",
month = "9",
day = "1",
doi = "10.1542/peds.2017-1904",
language = "English (US)",
volume = "140",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Clinical practice guideline for screening and management of high blood pressure in children and adolescents

AU - SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN

AU - Flynn, Joseph T.

AU - Kaelber, David C.

AU - Baker-Smith, Carissa M.

AU - Blowey, Douglas

AU - Carroll, Aaron

AU - Daniels, Stephen R.

AU - De Ferranti, Sarah D.

AU - Dionne, Janis M.

AU - Falkner, Bonita

AU - Flinn, Susan K.

AU - Gidding, Samuel S.

AU - Goodwin, Celeste

AU - Leu, Michael G.

AU - Powers, Makia E.

AU - Rea, Corinna

AU - Samuels, Joshua

AU - Simase, Madeline

AU - Thaker, Vidhu V.

AU - Urbina, Elaine M.

AU - Simasek, Madeline

AU - Okechukwu, Kymika

PY - 2017/9/1

Y1 - 2017/9/1

N2 - These pediatric hypertension guidelines are an update to the 2004 "Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents." Significant changes in these guidelines include (1) the replacement of the term "prehypertension" with the term "elevated blood pressure, " (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.

AB - These pediatric hypertension guidelines are an update to the 2004 "Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents." Significant changes in these guidelines include (1) the replacement of the term "prehypertension" with the term "elevated blood pressure, " (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.

UR - http://www.scopus.com/inward/record.url?scp=85028711536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028711536&partnerID=8YFLogxK

U2 - 10.1542/peds.2017-1904

DO - 10.1542/peds.2017-1904

M3 - Review article

C2 - 28827377

AN - SCOPUS:85028711536

VL - 140

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

M1 - e20171904

ER -